Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
8,727,390
-
Shares change
-
-1,566,277
-
Total reported value, excl. options
-
$18,332,069
-
Value change
-
-$3,514,295
-
Put/Call ratio
-
214%
-
Number of buys
-
16
-
Number of sells
-
-23
-
Price
-
$2.10
Significant Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q4 2022
52 filings reported holding CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share as of Q4 2022.
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,727,390 shares
of 95,490,450 outstanding shares and own 9.1% of the company stock.
Largest 10 shareholders include Long Focus Capital Management, LLC (2,683,633 shares), CREDIT SUISSE AG/ (1,438,255 shares), PRINCIPAL FINANCIAL GROUP INC (1,334,050 shares), MILLENNIUM MANAGEMENT LLC (679,966 shares), BAILLIE GIFFORD & CO (599,896 shares), Capital International Investors (448,804 shares), Capital World Investors (250,000 shares), D. E. Shaw & Co., Inc. (227,112 shares), MACQUARIE GROUP LTD (226,875 shares), and JANE STREET GROUP, LLC (211,467 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.